Article
Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
Department of Pathology, Hamanomachi Hospital, Fukuoka 810-8539, Japan.
American Journal of Surgical Pathology (impact factor:
4.35).
07/2007;
31(7):1059-67.
DOI:10.1097/PAS.0b013e31802b34b6
pp.1059-67
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas.
[show abstract] [hide abstract]
ABSTRACT: Hepatic cholangiocarcinomas are tumors with poor prognosis and with increasing incidence worldwide. The aim of the study was to compare morphological features and protein profiles of hilar and peripheral cholangiocarcinomas. Clinicopathological data were collected from 111 cholangiocarcinomas (59 peripheral and 52 hilar). Protein expression, assessed on tissue samples using tissue microarray and protein array technologies, was compared between both types of tumors and with extrahepatic cholangiocarcinoma and hepatocholangiocarcinoma. Hilar cholangiocarcinomas were smaller in size (mean: 2.7 vs. 8 cm, p<0.001), were more often well differentiated adenocarcinomas (65% vs. 36% well differentiated, p<0.01) and carried out stronger perineural invasion (83% vs. 42%, p<0.001) than peripheral cholangiocarcinomas. Regarding protein expression, hilar cholangiocarcinomas more often expressed MUC5AC (62% vs. 22%, p<0.0001), Akt2 (54% vs. 27%, p<0.001), CK8 (98% vs. 81%, p<0.005) and annexin II (92% vs. 66%, p<0.001). Interestingly, VEGF A expression was more frequently encountered in peripheral cholangiocarcinoma (69% vs. 25%, p<0.0001) and correlated with increased vascular density. Using protein array antibody, we identified filamin A as significantly overexpressed (>2-fold) in peripheral cholangiocarcinomas. Our results show that hilar and peripheral cholangiocarcinomas display specific protein profiles, especially regarding VEGF expression. This suggests a potential benefit for anti-angiogenic therapies in peripheral hepatic CCs.Journal of Hepatology 05/2009; 51(1):93-101. · 9.26 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
different level
different premalignant conditions
different tumor progression
events induces
frequent vascular invasion
hilar type
histologic features
intrahepatic cholangiocarcinoma
intrahepatic large
large biliary duct
large duct involvement
large tumor size
multivariate analysis
perineural invasion
peripheral type
prognostic factor
proper therapy
small biliary ducts
small tumor size
tumor periphery